ClinConnect ClinConnect Logo
Search / Trial NCT05612750

Comparative Effectiveness of Online 8-session CBT Vs. 1-Session Empowered Relief for Chronic Pain - the PROGRESS Study

Launched by STANFORD UNIVERSITY · Nov 4, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Young Adult Lupus Pelvic Pain Behavioral Health

ClinConnect Summary

The PROGRESS Study is a clinical trial designed to compare two different approaches for helping people manage chronic pain. One group of participants will receive 8 weeks of cognitive behavioral therapy (CBT), which involves a total of 16 hours of treatment aimed at changing the way they think about and respond to their pain. The other group will take part in a shorter, 1-session program called Empowered Relief, which focuses on teaching pain relief skills in just 2 hours. The study aims to see which method is more effective in helping individuals cope with their pain.

To participate in this study, you must be at least 18 years old and have chronic pain, meaning you experience pain on most days for three months or longer. Your average pain score should be at least a 3 out of 10 in the past month. It's important to note that those with certain conditions, like cognitive impairment or active suicidal thoughts, may not be eligible. If you decide to join, you can expect to either attend weekly sessions for the CBT program or participate in a single session for the Empowered Relief program. This research will help understand which treatment approach may be more beneficial for managing chronic pain.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. At least 18 years of age or older of either sex (and all genders).
  • 2. Chronic pain (pain that occurs on at least half of the days of 3 months or more).
  • 3. Past-month average pain intensity score of at least 3/10.
  • 4. Ability to adhere to and complete study protocols.
  • Exclusion Criteria:
  • 1. Inability to provide informed consent.
  • 2. Cognitive impairment, non-English speaking, or psychological factors that would preclude comprehension of material and/or full participation in the study including group treatment.
  • 3. Active suicidality at screening.
  • 4. Study staff may exclude individuals with a known history of disruptive behavior to minimize contamination of the learning environment for an entire treatment cohort.
  • 5. Receipt of either study treatment in the past 3 months.

About Stanford University

Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.

Locations

Phoenix, Arizona, United States

Allentown, Pennsylvania, United States

Salt Lake City, Utah, United States

Louisville, Kentucky, United States

Long Beach, California, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials